Please provide your email address to receive an email when new articles are posted on . Patients who received an endobronchial valve vs. lung volume reduction surgery had significantly heightened odds ...
One patient could only walk 15 to 20 steps before needing to get back on her oxygen, making it difficult to find motivation to engage in daily activities. Another patient struggled with severe ...
LONDON, United Kingdom — An endobronchial valve placed in the lung of a patient with homogeneous emphysema can lead to clinically meaningful improvements in lung function, exercise tolerance, and ...
Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease Breathe Easier and Have a Better Quality of Life Over 600,000 Japanese patients suffer from ...
In Tarrant County, patients with severe chronic obstructive pulmonary disease, COPD, now have access to a procedure that can lessen airflow blockage and improve their quality of life. KERA’s Sam Baker ...
CHICAGO, Oct. 22 – Emphysema patients whose lungs are implanted with a pencil eraser-sized, one-way endobronchial valve experience significantly improved measures of lung function and report better ...
Endobronchial valve treatment for emphysema is supported by a rich body of high-quality evidence, and is now a compelling alternative to lung volume reduction surgery (also evidence level A); ...
WHITTIER, Calif., Nov. 19, 2025 /PRNewswire/ -- PIH Health Whittier Hospital is now offering the Zephyr® Endobronchial Valve procedure, a breakthrough minimally invasive treatment option for patients ...
CENTER VALLEY, Pa., June 23, 2020 /PRNewswire/ -- Olympus recently announced an expansion of insurance coverage for the Spiration® Valve System, which has been demonstrated to improve quality of life ...
Please provide your email address to receive an email when new articles are posted on . Patients with severe emphysema who received an endobronchial valve had sustained improvements in lung function ...
REDWOOD CITY, Calif. & TOKYO--(BUSINESS WIRE)--Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announced today that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results